Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
Li Ka Shing Foundation, Temasek Pump SGD12M to Advance Histotripsy Cancer Therapy Clinical Trials
Recommend 17 Positive 42 Negative 12 |
||||
|
||||
|
The Li Ka Shing Foundation and Temasek Trust committed SGD12 million to introduce innovative non-invasive ultrasound histotripsy tumor treatment clinical trials to Singapore. The National Cancer Centre Singapore and the National University Cancer Institute, Singapore, will each receive a histotripsy system, being the first of its kind in Southeast Asia. The funding from the Li Ka Shing Foundation and Temasek Trust will also support clinical trials in Singapore for patients with liver, kidney, and pancreatic cancers, advancing regional cancer research and innovation. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
